First Manhattan’s GoodRx Holdings GDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-40
Closed -$284 908
2024
Q1
$284 Hold
40
﹤0.01% 1366
2023
Q4
$268 Buy
+40
New +$225 ﹤0.01% 1387
2022
Q4
Sell
-100
Closed 1733
2022
Q3
$0 Hold
100
﹤0.01% 1564
2022
Q2
$0 Hold
100
﹤0.01% 1594
2022
Q1
$1K Hold
100
﹤0.01% 1534
2021
Q4
$3K Hold
100
﹤0.01% 1440
2021
Q3
$4K Hold
100
﹤0.01% 1427
2021
Q2
$3K Hold
100
﹤0.01% 1472
2021
Q1
$3K Hold
100
﹤0.01% 1396
2020
Q4
$4K Buy
+100
New +$4.59K ﹤0.01% 1224

Other funds holding GDRX

First Manhattan's GDRX Position: Q2 2024 in Review

First Manhattan sold out of GoodRx Holdings (GDRX) in Q2 2024, closing a stake of 40 shares — an estimated $284 sold.

First Manhattan first reported a position in GDRX in Q4 2020 and held it in 10 quarters. The position peaked at $4K in Q3 2021. 165 funds tracked by Wall St. Rank hold GDRX as of Q2 2024.

  • First Manhattan reported no remaining GoodRx Holdings position as of Q2 2024 after selling out during the quarter.
  • First Manhattan sold 40 GoodRx Holdings shares in Q2 2024, an estimated $284.
  • First Manhattan first reported a position in GoodRx Holdings in Q4 2020 and held it in 10 quarters.
  • First Manhattan's GoodRx Holdings position peaked at $4K in Q3 2021.
  • 165 funds tracked by Wall St. Rank held GoodRx Holdings as of Q2 2024.

Based on First Manhattan's 13F filing for Q2 2024, filed 14 Aug 2024.